AstraZeneca was signed as Oxford’s partner on 30 April and signed a deal to supply 100m doses to the UK a fortnight later. Ministers were prepared to pay a few hundred million upfront, allowing the company to build its first virus manufacturing process.
theguardian.com/society/2021/j…
theguardian.com/society/2021/j…
The deal was - from the UK government - a demand its citizens be vaccinated first.
“That underpinned all of it,” an industry insider said.
Two sites (Oxford and Keele) were set up to start “brewing” the vaccine. There were early issues but were overcome in 3 months
“That underpinned all of it,” an industry insider said.
Two sites (Oxford and Keele) were set up to start “brewing” the vaccine. There were early issues but were overcome in 3 months
Bottling takes place in Wrexham....where the suspicious package was.
All credit to getting the manufacturing investment in place early enough to overcome inevitable early teething troubles and produce plenty of vaccine.
All credit to getting the manufacturing investment in place early enough to overcome inevitable early teething troubles and produce plenty of vaccine.
A weakness on the EU side is that their proportionate “risk”investment -€1.78 bn (ie with the possibility of no return) seems to be a lot lower that the U.K. (€1.9bn) or the USA (€9bn).
Is the EU’s “risk investment” enough to satisfy their “beat reasonable endeavours” in the contract?
In other words that requirement applies to both AZ and the EU.
In other words that requirement applies to both AZ and the EU.
Argh! Tweet one!
. “Vaccine manufacturing process” not “virus” manufacturing process.
Thanks @andrew_croxford for the nudge.
As if there aren’t enough conspiracy theories out there without me adding to them.
. “Vaccine manufacturing process” not “virus” manufacturing process.
Thanks @andrew_croxford for the nudge.
As if there aren’t enough conspiracy theories out there without me adding to them.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
